';
Home
About
Services
Our Works
Contact
News
Pricing
Disclaimer
Home
Posts Tagged "FDA"
News Features
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
March 26, 2020
by
Stock Market Media
in
News Features
More
Share
News Features
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
January 27, 2020
by
Stock Market Media
in
News Features
More
Share
News Features
PharmaCyte Biotech’s Release Testing Last Critical Event Before Submission of Investigational New Drug Application
November 12, 2019
by
Stock Market Media
in
News Features
More
Share
News Features
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology
October 28, 2019
by
Stock Market Media
in
News Features
More
Share
News Features
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
October 16, 2019
by
Stock Market Media
in
News Features
More
Share
News Features
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
February 4, 2019
by
Stock Market Media
in
News Features
More
Share
News Features
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancreatic Cancer
January 23, 2019
by
Stock Market Media
in
News Features
More
Share
Media
PharmaCyte Biotech CEO and CSO Interviewed on IND, Planned Clinical Trial in Pancreatic Cancer, CRO and More
May 30, 2018
by
Stock Market Media
in
Media
More
Share
Search for:
